EDGAR Filing Documents for 0001140361-17-009132

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001140361-17-009132

Filing Date

2017-02-24

Accepted

2017-02-24 16:16:32

Documents

Period of Report

2016-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	REXAHN PHARMACEUTICALS 10-K 12-31-2016	form10k.htm	10-K	1467872
2	EXHIBIT 12.1	ex12_1.htm	EX-12.1	32025
3	EXHIBIT 23.1	ex23_1.htm	EX-23.1	2380
4	EXHIBIT 24.1	ex24_1.htm	EX-24.1	12170
5	EXHIBIT 31.1	ex31_1.htm	EX-31.1	11940
6	EXHIBIT 31.2	ex31_2.htm	EX-31.2	11646
7	EXHIBIT 32.1	ex32_1.htm	EX-32.1	6567
8	EXHIBIT 32.2	ex32_2.htm	EX-32.2	6474
15		image00001.jpg	GRAPHIC	29032
16		image00002.jpg	GRAPHIC	3848
	Complete submission text file	0001140361-17-009132.txt		7577374

Data Files

Seq	Description	Document	Type	Size
9	XBRL INSTANCE DOCUMENT	rnn-20161231.xml	EX-101.INS	1868588
10	XBRL TAXONOMY EXTENSION SCHEMA	rnn-20161231.xsd	EX-101.SCH	69217
11	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	rnn-20161231_cal.xml	EX-101.CAL	48751
12	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	rnn-20161231_def.xml	EX-101.DEF	157786
13	XBRL TAXONOMY EXTENSION LABEL LINKBASE	rnn-20161231_lab.xml	EX-101.LAB	427623
14	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	rnn-20161231_pre.xml	EX-101.PRE	367803

Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850

Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300

REXAHN PHARMACEUTICALS, INC. (Filer) CIK: 0001228627 (see all company filings)